RUPURUT

Chewable tablet, 500 mg
OTCActive license

Active substance (INN)

hydrotalcite

Pharmaceutical form

Pharmaceutical formChewable tablet
Strength500 mg
PackagingUkupno 50 tableta za žvakanje u blisteru (5x10) u kartonskoj kutiji
ManufacturerBayer Bitterfeld GmbH, Germany
Therapeutic groupAlimentary tract and metabolism (A02AD04)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateDecember 9, 2024

Analogs in Montenegro

2

Other medicines with the same active substance

RUPURUTOTC
Chewable tablet, 500mgBayer Bitterfeld GmbH
RUTACIDOTC
Chewable tablet, 500 mgKrka d.d.
Source: CInMED register